RBC Capital analysts reiterated a Outperform rating on Johnson & Johnson (NYSE:JNJ) on February 03, 2026.
Johnson & Johnson operates in the Healthcare sector. The stock currently trades at $233.10 with a market capitalization of $505.8B. The stock has gained 32.5% over the past 52 weeks.
